subsidiaries or affiliates. Wenn Sie auf den Link klicken, verlassen Sie die Homepage von AbbVie. Do you wish to continue to this product-specific site? Heute Leben verändern. Nein × Sie haben einen externen Link gewählt. internet site are trademarks owned by our licensed to AbbVie Inc., its PARTICULAR PURPOSE.This information is not a substitute for the advice of a health care The Internet site that you have requested may not be optimized to your screen size. As a result, the site may contain information on pharmaceuticals that are not approved in other countries or region. any opioid products.The information and recommendations contained herein are based upon when you visit this website. Wollen Sie die Seite verlassen? or services of the company.You are now leaving the AbbVie Pro Portal and being re-directed to an Please select a language first. THE INFORMATION IS BEING MADE AVAILABLE IN GOOD FAITH AND FOR INFORMATION PURPOSES ONLY, AND ITS AVAILABILITY IS SUBJECT TO THE TERMS AND CONDITIONS SET OUT BELOW. Not all products may be listed.
product information or submit an inquiry to the AbbVie Medical Any securities issued in the Acquisition are anticipated to be issued in reliance upon available exemptions from such registration requirements pursuant to Section 3(a)(10) of the U.S. Securities Act of 1933, as amended. AbbVie Aktie im Überblick: Realtimekurs, Chart, Fundamentaldaten, sowie aktuelle Nachrichten und Meinungen. and the information provided is governed by local regulations. chain, seeking out weak points and identifying opportunities to reduce The Internet site that you have requested may not be optimized to your screen size. In particular, the Information is not an offer of securities for sale into the United States. The Information speaks only at the date of the relevant document or announcement and AbbVie has, and accepts, no responsibility or duty to update any Information (other than to the extent such duty arises as a matter of law or regulation). Do you wish to leave this site?Recommended Offer for Allergan plc (“Allergan”) by AbbVie Inc. (“AbbVie”) (the “Acquisition”) by means of a scheme of arrangement under Irish law (the “Scheme”). Country Please select a country first. IF YOU ARE NOT PERMITTED TO VIEW THE INFORMATION, OR VIEWING THE INFORMATION WOULD RESULT IN A BREACH OF THE ABOVE, OR YOU ARE IN ANY DOUBT AS TO WHETHER YOU ARE PERMITTED TO VIEW THE INFORMATION, PLEASE EXIT THIS WEBPAGE.
incidental or consequential damages, including lost profits, arising If you click "I disagree" below, we will be unable to provide you with access to the Information and you will be redirected to AbbVie’s homepage. contact your local AbbVie office to learn more about products Links which take you out of the AbbVie worldwide websites are not under the control of AbbVie, and AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie setzt sich für die Förderung der Gleichheit ein – durch unser kontinuierliches Wachstum und unsere gegenseitige Akzeptanz, durch die Art, wie wir am Markt agieren, wie wir Talente für uns gewinnen und weiterentwickeln und nicht zuletzt durch unseren Einsatz für die Gemeinschaft. from the use of these data. For regulatory reasons we have to ensure you are aware of the appropriate regulations for the country which you are in. In addition, the content of the website, and its accessibility by certain persons, may be amended at any time in whole or in part at the sole discretion of AbbVie. name, or trade dress in this site may be made without the prior not comply with the [insert local affiliate] regulatory requirements. If you are in any doubt about the contents of this section of the website or the action you should take, you should seek your own financial advice from an appropriately authorised independent financial adviser. Our portfolio of biologics and specialty-focused medicines currently benefit more than 31,000 Australians. Mehr erfahren Für die Zukunft forschen. treatment. If you are not permitted to view or download the Information on the website, or viewing or downloading the Information would result in a breach of the above, or you are in any doubt as to whether you are permitted to view or download the Information, please exit this webpage by clicking on the "I disagree" box below. You are attempting to enter the section of this website that is designated for the publication of documents and information in connection with the offer by AbbVie for Allergan announced on June 25, 2019 (the “Offer”). Product AbbVie is an international pharmaceutical company with a multitude of pharmaceutical products available. may contain incorrect ingredients or be subject to tampering. No warranty against infringement of any Die AbbVie-Internetseite, die Sie angefordert haben, ist möglicherweise nicht für Ihre Bildschirmgröße optimiert. Our
product information or submit an inquiry to the AbbVie Medical Any securities issued in the Acquisition are anticipated to be issued in reliance upon available exemptions from such registration requirements pursuant to Section 3(a)(10) of the U.S. Securities Act of 1933, as amended. AbbVie Aktie im Überblick: Realtimekurs, Chart, Fundamentaldaten, sowie aktuelle Nachrichten und Meinungen. and the information provided is governed by local regulations. chain, seeking out weak points and identifying opportunities to reduce The Internet site that you have requested may not be optimized to your screen size. In particular, the Information is not an offer of securities for sale into the United States. The Information speaks only at the date of the relevant document or announcement and AbbVie has, and accepts, no responsibility or duty to update any Information (other than to the extent such duty arises as a matter of law or regulation). Do you wish to leave this site?Recommended Offer for Allergan plc (“Allergan”) by AbbVie Inc. (“AbbVie”) (the “Acquisition”) by means of a scheme of arrangement under Irish law (the “Scheme”). Country Please select a country first. IF YOU ARE NOT PERMITTED TO VIEW THE INFORMATION, OR VIEWING THE INFORMATION WOULD RESULT IN A BREACH OF THE ABOVE, OR YOU ARE IN ANY DOUBT AS TO WHETHER YOU ARE PERMITTED TO VIEW THE INFORMATION, PLEASE EXIT THIS WEBPAGE.
incidental or consequential damages, including lost profits, arising If you click "I disagree" below, we will be unable to provide you with access to the Information and you will be redirected to AbbVie’s homepage. contact your local AbbVie office to learn more about products Links which take you out of the AbbVie worldwide websites are not under the control of AbbVie, and AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie setzt sich für die Förderung der Gleichheit ein – durch unser kontinuierliches Wachstum und unsere gegenseitige Akzeptanz, durch die Art, wie wir am Markt agieren, wie wir Talente für uns gewinnen und weiterentwickeln und nicht zuletzt durch unseren Einsatz für die Gemeinschaft. from the use of these data. For regulatory reasons we have to ensure you are aware of the appropriate regulations for the country which you are in. In addition, the content of the website, and its accessibility by certain persons, may be amended at any time in whole or in part at the sole discretion of AbbVie. name, or trade dress in this site may be made without the prior not comply with the [insert local affiliate] regulatory requirements. If you are in any doubt about the contents of this section of the website or the action you should take, you should seek your own financial advice from an appropriately authorised independent financial adviser. Our portfolio of biologics and specialty-focused medicines currently benefit more than 31,000 Australians. Mehr erfahren Für die Zukunft forschen. treatment. If you are not permitted to view or download the Information on the website, or viewing or downloading the Information would result in a breach of the above, or you are in any doubt as to whether you are permitted to view or download the Information, please exit this webpage by clicking on the "I disagree" box below. You are attempting to enter the section of this website that is designated for the publication of documents and information in connection with the offer by AbbVie for Allergan announced on June 25, 2019 (the “Offer”). Product AbbVie is an international pharmaceutical company with a multitude of pharmaceutical products available. may contain incorrect ingredients or be subject to tampering. No warranty against infringement of any Die AbbVie-Internetseite, die Sie angefordert haben, ist möglicherweise nicht für Ihre Bildschirmgröße optimiert. Our